BioVie Inc. Increase (Decrease) in Accounts Payable
BioVie Inc. (BIVI) reported Increase (Decrease) in Accounts Payable of $1.50 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- BioVie Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.09M.
- BioVie Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.31M, a 220.00% decline year-over-year.
- BioVie Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.36M.
- BioVie Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$633.96K.
- BioVie Inc. increase (decrease) in accounts payable for fiscal 2026 was $1.50M.
- BioVie Inc. increase (decrease) in accounts payable for fiscal 2025 was -$1.39M.
- BioVie Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.03M, a 28.55% decline from fiscal 2022.
- BioVie Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.45M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.09M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $781.42K derived: sum of 2 quarters · filed 2026-08-13 | $2.14M derived: sum of 3 quarters · filed 2026-08-13 | $1.50M 10-K · filed 2026-08-13 | |
| 2026-03-31 | -$1.31M derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | $44.95K derived: sum of 2 quarters · filed 2026-08-06 | -$589.01K S-1/A · filed 2026-08-06 | -$864.53K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | $723.02K 10-Q · filed 2026-02-06 | $447.50K derived: sum of 3 quarters · filed 2026-08-13 | $1.54M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | -$633.96K 10-Q · filed 2025-11-10 | -$909.48K derived: sum of 2 quarters · filed 2026-08-13 | $183.86K derived: sum of 3 quarters · filed 2026-08-13 | -$1.89M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$275.52K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $817.82K derived: sum of 2 quarters · filed 2026-08-13 | -$1.25M derived: sum of 3 quarters · filed 2026-08-13 | -$1.39M 10-K · filed 2026-08-13 | |
| 2025-03-31 | $1.09M derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | -$977.13K derived: sum of 2 quarters · filed 2026-08-06 | -$1.11M S-1/A · filed 2026-08-06 | -$1.93M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | -$2.20M 10-Q · filed 2026-02-06 | -$3.03M derived: sum of 3 quarters · filed 2026-08-06 | -$2.23M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-09-30 | -$133.94K 10-Q · filed 2025-11-10 | -$956.78K derived: sum of 2 quarters · filed 2026-08-06 | -$155.12K derived: sum of 3 quarters · filed 2026-08-06 | $738.21K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-06-30 | -$822.84K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | -$21.18K derived: sum of 2 quarters · filed 2026-08-06 | $872.15K derived: sum of 3 quarters · filed 2026-08-06 | $110.65K S-1/A · filed 2026-08-06 | |
| 2024-03-31 | $801.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $1.69M derived: sum of 2 quarters · filed 2025-05-12 | $933.50K 10-Q · filed 2025-05-12 | -$429.45K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $893.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $131.84K 10-Q · filed 2025-02-11 | -$1.23M derived: sum of 3 quarters · filed 2025-02-11 | $362.68K derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-09-30 | -$761.50K 10-Q · filed 2024-11-13 | -$2.12M derived: sum of 2 quarters · filed 2024-11-13 | -$530.65K derived: sum of 3 quarters · filed 2024-11-13 | $92.43K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $230.84K derived: sum of 2 quarters · filed 2024-09-30 | $853.92K derived: sum of 3 quarters · filed 2024-09-30 | $1.03M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $2.22M derived: sum of 2 quarters · filed 2024-05-14 | $2.40M 10-Q · filed 2024-05-14 | $3.63M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $623.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $802.61K 10-Q · filed 2024-02-13 | $2.04M derived: sum of 3 quarters · filed 2024-02-13 | $1.58M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $179.53K 10-Q · filed 2023-11-08 | $1.42M derived: sum of 2 quarters · filed 2023-11-08 | $209.95K 10-Q · filed 2022-05-11 | $1.94M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $779.72K derived: sum of 2 quarters · filed 2023-08-16 | $1.76M derived: sum of 3 quarters · filed 2023-08-16 | $1.45M 10-K · filed 2023-08-16 | |
| 2022-03-31 | -$456.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $526.93K derived: sum of 2 quarters · filed 2023-05-12 | $209.95K 10-Q · filed 2023-05-12 | -$222.11K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $983.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $666.72K 10-Q · filed 2023-02-10 | $234.66K derived: sum of 3 quarters · filed 2023-02-10 | $1.34M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-09-30 | -$316.98K 10-Q · filed 2022-11-04 | -$749.04K derived: sum of 2 quarters · filed 2022-11-04 | $169.23K 10-Q · filed 2022-05-11 | $476.22K derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | -$432.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $673.95K derived: sum of 2 quarters · filed 2022-09-27 | $793.20K derived: sum of 3 quarters · filed 2022-09-27 | -$262.83K 10-K · filed 2022-09-27 | |
| 2021-03-31 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | $1.23M derived: sum of 2 quarters · filed 2022-02-08 | $169.23K 10-Q · filed 2021-05-10 | $128.31K derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-12-31 | $119.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | -$936.78K 10-Q · filed 2022-02-08 | -$977.69K derived: sum of 3 quarters · filed 2022-02-08 | -$762.75K derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-09-30 | -$1.06M 10-Q · filed 2021-11-10 | -$1.10M derived: sum of 2 quarters · filed 2021-11-10 | -$882.00K derived: sum of 3 quarters · filed 2021-11-10 | -$480.89K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$40.91K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $174.03K derived: sum of 2 quarters · filed 2021-08-30 | $575.15K derived: sum of 3 quarters · filed 2021-08-30 | $815.73K 10-K · filed 2021-08-30 | |
| 2020-03-31 | $214.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | $616.06K derived: sum of 2 quarters · filed 2021-05-10 | $856.64K 10-Q · filed 2021-05-10 | $1.12M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $401.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-29 | $641.70K 10-Q · filed 2021-01-29 | $906.12K derived: sum of 3 quarters · filed 2021-01-29 | $980.34K derived: sum of 4 quarters · filed 2021-01-29 | |
| 2019-09-30 | $240.58K 10-Q · filed 2020-11-05 | $505.01K derived: sum of 2 quarters · filed 2020-11-05 | $579.23K derived: sum of 3 quarters · filed 2020-11-05 | $185.57K derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $264.43K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $338.64K derived: sum of 2 quarters · filed 2020-08-07 | -$55.01K derived: sum of 3 quarters · filed 2020-08-07 | -$117.78K 10-K/A · filed 2020-08-07 | |
| 2019-03-31 | $74.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$319.44K derived: sum of 2 quarters · filed 2020-05-13 | -$382.20K 10-Q · filed 2020-05-13 | -$244.25K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | -$393.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | -$456.42K 10-Q · filed 2020-02-13 | -$318.47K derived: sum of 3 quarters · filed 2020-02-13 | -$201.43K derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | -$62.77K 10-Q · filed 2019-11-19 | $75.18K derived: sum of 2 quarters · filed 2019-11-19 | $192.22K derived: sum of 3 quarters · filed 2019-11-19 | $353.66K derived: sum of 4 quarters · filed 2019-11-19 | |
| 2018-06-30 | $137.95K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $254.99K derived: sum of 2 quarters · filed 2019-09-27 | $416.42K derived: sum of 3 quarters · filed 2019-09-27 | $413.23K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $117.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $278.47K derived: sum of 2 quarters · filed 2019-05-10 | $275.28K 10-Q · filed 2019-05-10 | $275.28K 10-Q · filed 2018-05-14 | $416.14K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $161.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | $158.25K 10-Q · filed 2019-02-12 | $299.10K derived: sum of 3 quarters · filed 2019-02-12 | $296.30K derived: sum of 4 quarters · filed 2019-02-12 | |
| 2017-09-30 | -$3.19K 10-Q · filed 2018-11-14 | $137.67K derived: sum of 2 quarters · filed 2018-11-14 | $134.86K derived: sum of 3 quarters · filed 2018-11-14 | $259.83K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $140.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $138.05K derived: sum of 2 quarters · filed 2018-10-05 | $263.02K derived: sum of 3 quarters · filed 2018-10-05 | $350.67K 10-K · filed 2018-10-05 | |
| 2017-03-31 | -$2.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $122.16K derived: sum of 2 quarters · filed 2018-05-14 | $209.82K 10-Q · filed 2018-05-14 | ||
| 2016-12-31 | $124.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $212.62K 10-Q · filed 2018-02-14 | |||
| 2016-09-30 | $87.66K 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | $42.79K 10-K · filed 2017-08-24 | ||||
| 2015-09-30 | $8.84K 10-Q/A · filed 2017-01-19 | $8.84K derived: sum of 2 quarters · filed 2017-01-19 | $4.55K derived: sum of 3 quarters · filed 2017-01-19 | $7.69K derived: sum of 4 quarters · filed 2017-01-19 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$4.29K derived: sum of 2 quarters · filed 2016-09-28 | -$1.15K derived: sum of 3 quarters · filed 2016-09-28 | $650.00 10-K · filed 2016-09-28 | |
| 2015-03-31 | -$4.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | -$1.15K derived: sum of 2 quarters · filed 2016-05-23 | $650.00 10-Q · filed 2016-05-23 | -$1.85K derived: sum of 4 quarters · filed 2016-05-23 | |
| 2014-12-31 | $3.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | $4.95K 10-Q · filed 2016-02-16 | $2.44K derived: sum of 3 quarters · filed 2016-02-16 | $4.95K derived: sum of 4 quarters · filed 2016-02-16 | |
| 2014-09-30 | $1.80K 10-Q · filed 2015-11-13 | -$700.00 derived: sum of 2 quarters · filed 2015-11-13 | $1.80K derived: sum of 3 quarters · filed 2015-11-13 | -$6.84K derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | -$2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-01 | $0.00 derived: sum of 2 quarters · filed 2015-10-01 | -$8.64K derived: sum of 3 quarters · filed 2015-10-01 | -$15.00K 10-K · filed 2015-10-01 | |
| 2014-03-31 | $2.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | -$6.14K derived: sum of 2 quarters · filed 2015-05-11 | -$12.50K 10-Q · filed 2015-05-11 | -$2.50K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$8.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$15.00K 10-Q · filed 2015-02-05 | |||
| 2013-09-30 | -$6.36K 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $15.00K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |